CNS vs STEP

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

CNS

38.7
AI Score
VS
CNS Wins

STEP

37.7
AI Score

Investment Advisor Scores

CNS

39score
Recommendation
SELL

STEP

38score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric CNS STEP Winner
Forward P/E 22.3714 20.3252 STEP
PEG Ratio 2.0458 0 Tie
Revenue Growth 12.2% 4.0% CNS
Earnings Growth 31.9% -38.5% CNS
Tradestie Score 38.7/100 37.7/100 CNS
Profit Margin 28.8% -30.5% CNS
Beta 1.00 1.00 Tie
AI Recommendation SELL SELL Tie

Relative Price Performance (Last 90 Days)

CNS 1M: +1.8% · 3M: +12.8% STEP 1M: +23.2% · 3M: -8.7%

Current Technical Phase

CNS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.9 · Price: $81.42

STEP

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 57.0 · Price: $49.99

Fundamentals Snapshot

Metric CNS STEP
Market Cap
Forward P/E 20.5 19.3
Trailing P/E 25.0
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 0.5% -0.5%
Operating Margin 0.3% -0.5%
EPS 3.23 -7.70
Dividend Yield 0.03% 0.02%

Frequently Asked Questions

Based on our detailed analysis, CNS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.